GeneDx Holdings's market cap is currently $3.37B. The company's EPS TTM is $0.5; its P/E ratio is 6,267.91; GeneDx Holdings is scheduled to report earnings on July 29, 2025, and the estimated EPS forecast is $0.41. See an overview of income statement, balance sheet, and cash flow financials.
